baber/WOPTO huggingface dataset:
Patent DE-69209877-D1 (DE)
Inventor: ARRAUDEAU JEAN-PIERRE
IPC: A61K8/29
Filed: 1992-02-28
Granted: 1996-05-23
Abstract: Cosmetic composition comprising a dispersion, in a fatty binding agent, of a filler consisting of solid particles of at least one material compatible with application to the skin, characterised in that the said filler contains not less than 50 % by weight, or not less than 75 % by volume, relative to the total filler, of spherical or spheroidal particles 0.5 to 50  mu m in size, in that the said filler has an oil content such that its concentration by volume C<*>, when the volume of the binding agent is equal to that of the oil content (measured on the non-volatile fraction of the binding agent), is between 3 and 90 %, and in that the concentration by volume of the filler, in the said dispersion, measured on the non-volatile fraction of the binding agent, that is to say without taking into account the volatile oils which may be present in the fatty binding agent, is not less than C<*> and preferably greater than C<*>. 
<??>This composition makes it possible to attenuate skin defects (differences in coloration, microreliefs) while leaving a translucent layer on it.
Patent DE-69213573-D1 (DE)
Inventor: JACOBSEN STEPHEN C
IPC: G01B7/16
Filed: 1992-06-11
Granted: 1996-10-17
Abstract: Linear displacement and strain measuring apparatus includes a linearly movable element, an emitter disposed on the movable element to move as the element is moved, for developing predetermined patterns of electric fields which vary linearly on the emitter in the direction of movement of the element, and a detector disposed in close proximity to the emitter adjacent the path in which moves to detect variations in the electric field patterns as the emitter is moved, for producing output signals representing variation in the electric field patterns and thus the linear displacement of the movable element relative to the detector. By attaching the movable element and the detector to spaced apart locations on a specimen, strain in the specimen can be measured. <IMAGE>
Patent DE-69216425-D1 (DE)
Inventor: DENNESEN JAMES
IPC: A63B69/36
Filed: 1992-11-04
Granted: 1997-02-13
Abstract: A method and apparatus for the measurement of the driving distance of a golf swing by measuring the initial velocity of a golf ball tethered by a string to a rotating axle.
Patent DE-69217081-D1 (DE)
Inventor: ANDERSSON ROINE
IPC: B04C5/081
Filed: 1992-11-26
Granted: 1997-03-06
Abstract: PCT No. PCT/SE92/00814 Sec. 371 Date Jun. 1, 1994 Sec. 102(e) Date Jun. 1, 1994 PCT Filed Nov. 26, 1992 PCT Pub. No. WO93/10908 PCT Pub. Date Jun. 10, 1993.In a hydrocyclone the separation chamber (2) has a circumferential wall (3) provided with at least one turbulence creating member (12), which extends along the circumferential wall and crosses a helical path (10) along which a liquid stream is generated during operation. According to the invention, the turbulence creating member is formed by an offset (12) on the circumferential wall (3). The offset is formed and dimensioned such that said liquid stream substantially loses its contact with the circumferential wall as the liquid stream passes the offset. As a result turbulence is created in a layer of the liquid stream situated closest to the circumferential wall, without the liquid stream developing any substantial flow component directed inward in the separation chamber.
Patent DE-69224918-D1 (DE)
Inventor: CHARAMATHIEU ANDRE
IPC: G01N1/02
Filed: 1992-09-04
Granted: 1998-04-30
Abstract: A device and method for picking up dirt from a surface in order to measure the cleanliness thereof. The device is essentially characterized in that it uses no implement such as a brush to detach dirt, but only a fluid such as a liquid held in a cup-like enclosure (1). The dirt is removed by loosening devices such as ultrasonic generators (18, 28) and carried off by the liquid. A plunger (7) is slidable in the enclosure (1) and generates currents therein which suspend the dirt. Measurement may involve counting particles or measuring the absorbency of the fluid either on the spot or elsewhere after sampling part of the fluid.
Patent DE-69230345-D1 (DE)
Inventor: EVANS GLEN
IPC: C12Q1/68
Filed: 1992-10-07
Granted: 1999-12-30
Abstract: Nucleotide sequence defining a polymorphic locus useful for identification of an individual. Also disclosed are oligonucleotide primers useful in amplification of the locus and methods for detecting the amplified locus.
Patent DE-69231689-D1 (DE)
Inventor: SUCOV M
IPC: C12Q1/68
Filed: 1992-03-13
Granted: 2001-03-22
Abstract: DNA segments have been discovered, and characterized by sequence, which are response elements operative to confer responsiveness to ligands for several members of the steroid/thyroid superfamily of receptors, for the transcriptional activation and/or repression of promoters in cells. By using transcriptional control regions comprising response elements of the present invention in combination with a functional promoter, it is now possible to provide recombinant DNA vectors containing a gene, the transcription (and, thereby, also expression) of which is under the control of a promoter, the transcriptional activity of which is responsive to ligands for members of the steroid/thyroid superfamily of receptors.
Patent DE-69233623-D1 (DE)
Inventor: RUGGERI M
IPC: A61K39/395
Filed: 1992-12-23
Granted: 2006-06-08
Abstract: A method of inhibiting platelet transfusion refractoriness comprising administering third-party platelets to a patient whose platelet glycoprotein Ib alpha  polypeptides expressed from the patient's DNA have been determined to have either threonine or methionine residues, or both, at amino acid residue position 145 thereof, the third-party platelets having expressed at residue position 145 of the glycoprotein Ib alpha  polypeptide thereof amino acids that are the same as those expressed on the glycoprotein Ib alpha  polypeptides of the patient's platelets. Also, an antibody, or a fragment thereof, in substantially pure form having as its target epitope a domain of glycoprotein Ib alpha , the affinity of the antibody, or fragment thereof, for said epitope being dependent on the identity of the amino acid residue at position 145 of the glycoprotein. In addition, in a process for storing a supply of platelets for therapeutic use in a patient, the improvement comprising segregating the platelets into three stocks dependent upon whether residue 145 of glycoprotein Ib alpha  polypeptides of the platelets includes: (A) threonine; (B) methionine; or (C) both threonine and methionine. Also, a method of immunoassay comprising contacting a sample of blood, or a composition derived therefrom, with alloantigenic Thr or Met145 form of glycoprotein Ib alpha , or a fragment thereof, containing the Thr/Met145 locus, and determining whether there is present a complex of antibody and a form of the glycoprotein or a fragment thereof.
Patent DE-69301921-D1 (DE)
Inventor: MILLER RICHARD
IPC: A61F13/58
Filed: 1993-07-26
Granted: 1996-04-25
Abstract: An elastomeric composition is prepared containing an amorphous propylene/hexene copolymer and an elastomer selected from styrene butydiene styrene block copolymers.
Patent DE-69302010-D1 (DE)
Title: Tier futterer
Inventor: RASMUSSEN HANS
IPC: A01K5/02
Filed: 1993-01-08
Granted: 1996-05-02
Abstract: PCT No. PCT/DK93/00008 Sec. 371 Date Aug. 22, 1994 Sec. 102(e) Date Aug. 22, 1994 PCT Filed Aug. 1, 1993 PCT Pub. No. WO93/13652 PCT Pub. Date Jul. 22, 1993.A feeding device for feeding animals, such as pigs or hogs, includes a tubular feed reservoir (16) and a feed discharge tube 27 having a feed discharge opening at its lower end (17) above a base member (10) defining a feed support surface (12). Troughs (11) may be arranged adjacent to the feed support surface (12), and the bottom surfaces (13) of the troughs are located on a lower level than the feed support surface (12). The feed reservoir (16) is suspended at its upper part in a pendulum-like manner and transverse movement of the reservoir is restricted by an encircling ring member (18). Animals being fed may push the lower end of the feed discharge tube (27) so that the lower end thereof is moved transversely. The lower length (31) of the feed discharge tube (27) is elastically flexible such that it may be flexed by larger pigs or animals, whereby the lower end of the feed discharge tube (27) may be moved further relative to the base member (10). Thus, the discharge rate of feed adapts itself to the size of the animals being fed.
Patent DE-69302852-D1 (DE)
Inventor: VAN DER WAL GILLIS P
IPC: A61M5/20
Filed: 1993-03-16
Granted: 1996-07-04
Abstract: The invention relates to an automatic injector, in which, prior to use, different substances which are not allowed to be in contact with each other for a long period of time, can be stored separately, one of said substances being a solid and another being or comprising a solvent for this solid, which solid can be injected as an injection liquid after dissolving it in said solvent; said injector comprising a discharge mechanism (46), a cartridge assembly (25), and a front cover (30), connected to a front portion of said cartridge assembly and provided at its front with a pierceable central area (31);  said cartridge assembly comprising:   a hollow barrel (26) having a backward portion with a cylindrical inner surface and a front portion, a pierceable stopper (28) sealingly connected to the front portion of the barrel and constituting a compartment in front of said stopper for accommodating the solid, a piston (33) slidably accommodated in the backward portion of the barrel and constituting a compartment for liquid in said barrel, an injection needle (35) longitudinally extending in said liquid compartment, and a means (36) for centring the distal end of the needle in order to position the needle tip towards the pierceable stopper; said front cover being capable of rotational movement relative to the outer sleeve (20), which movement causes a backward movement of the barrel in the cartridge container (22), the piston and the needle bearing thereon remaining in their places, as a result of which the injection needle pierces the pierceable stopper and allows the liquid in the barrel to reach the solid compartment through the needle.   <IMAGE>
Patent DE-69309453-D1 (DE)
Inventor: BOFFITO CLAUDIO
IPC: H01M10/50
Filed: 1993-10-11
Granted: 1997-05-07
Abstract: A thermally insulating jacket under reversible vacuum, having an inner wall (2), an outer wall (3) and an inner space (4) between said walls in fluid communication with an outer housing (6; 6'; K) containing a reversible non-evaporable hydrogen getter (7; 7') loaded with hydrogen before use, wherein:   a) said reversible hydrogen getter (7; 7') has a hydrogen equilibrium pressure (Px1) lower than 100 mbar at 500 DEG C, when the hydrogen concentration in the getter is 0.1% b.w., and is kept at a variable or constant temperature (Ti) essentially different from the temperature (Tc) of the hotter wall of the jacket; b) said inner space (4) contains a non-evaporable promoter getter (9;9';9'') having a hydrogen equilibrium pressure (Px2) higher than 100 mbar at 500 DEG C, when the hydrogen concentrationin the getter is 0.1% b.w., which is essentially exposed to said temperature (Tc).   <IMAGE>
Patent DE-69311709-D1 (DE)
Inventor: WANG RICHARD
IPC: C08L23/02
Filed: 1993-03-19
Granted: 1997-07-24
Abstract: Disclosed is a class of bis(phenolic-amine)quinone compounds which are useful as stablizers for polyolefins. The bis(phenolic-amine)quinone compounds inhibit oxidative degradation of polyolefins which is attributable to heat and/or ultraviolet light and is promoted or accelerated by metals, e.g., copper, in contact with the polyolefin. The compounds also exhibit excellent thermal stability.
Patent DE-69316601-D1 (DE)
Inventor: IACOB MIHAI
IPC: A61M25/10
Filed: 1993-06-23
Granted: 1998-02-26
Abstract: The catheter comprises a perfusion catheter (1), a balloon (2) connected by its distal end to a conduit (7) and by its proximal end to an inflating tube (11), a guide wire (5) inside the conduit (7), a dilator member (8) in the perfusion catheter around the conduit and with a tapered front portion (9), and side orifices (12, 14) in the walls of the perfusion catheter and of the conduit before the balloon to allow blood flow. Upon usage, only the guide wire (5) and conduit (7) dragging the deflated balloon (2) are inserted into the stenosis, the balloon is then inflated a short while to break the stenosis and thereafter deflated to permit insertion of the perfusion catheter therein by means of the dilator member; the dilator member and guide wire are then withdrawn and the balloon is re-inflated for supporting the vessel wall. <IMAGE>
Patent DE-69322426-D1 (DE)
Inventor: SLADE BRIAN PARRY
IPC: B65D35/22
Filed: 1993-03-29
Granted: 1999-01-21
Abstract: Means for dispensing simultaneously two liquids held in respective flexible containers (2,24), one within the other, comprise concentric tubular passages (16,38) for flows of the liquids from their containers when pressure is applied to the outer container. The inner passage has a narrow elongate form and terminates within the outer passage a final exit section of which provides a common conduit for both flows. A reduced liquid pressure is produced at the inner passage termination by having a tapered upstream end (52) of said conduit overlapping said termination and the conduit is configured to inhibit mixing of the flows along its length. The two liquids are thus dispensed in a single stream in which an, eg. coloured, flow from the inner passage is visible in the core of the stream. By adjusting the position of said conduit taper (52) relative to the inner passage termination it is possible to vary the proportions of the two components in the flow. <IMAGE>
Patent DE-69411444-D1 (DE)
Inventor: STROUD HERBERT D
IPC: D01F6/90
Filed: 1994-04-22
Granted: 1998-08-13
Abstract: The present invention is directed to a monofilament made from a blend of a polyester having a polyhydric alcohol of 1,4-cyclohexane-dimethanol, and a polyamide. Additionally, the blend may include a polyolefin. This blend is useful as an article of paper making machine clothing used in forming, pressing, or drying sections of a paper making machine when the blend is in the form of a fiber structure. The blends usefulness stems from its dry-heat strength and hydrolysis resistance.
Patent DE-69413956-D1 (DE)
Inventor: MALONE THOMAS
IPC: G06F9/44
Filed: 1994-02-25
Granted: 1998-11-19
Abstract: A computer system for displaying representations of processes, including models of complex business transactions in an information management system. The system includes a memory for storing the representations of the processes. The representation of a process includes an indication of processes into which the process is decomposed. Additionally, specializations of the process are represented. Alternatively, the dependencies among processes in a decomposition are indicated along with associated coordination processes. An indication of where a process is used within another process may also be provided. Specializations may also be bundled together to allow for evaluation of alternatives within a bundle.
Patent DE-69422788-D1 (DE)
Inventor: BRETTON RANDOLPH H
IPC: A61F9/007
Filed: 1994-11-18
Granted: 2000-03-02
Abstract: A method and apparatus for destroying residual lens epithelial cells within a lens capsule of an eye. The apparatus includes a probe configured for insertion into the eye such that the probe is disposed either in the lens capsule or between the iris and the lens capsule. The probe is further configured to deliver energy therefrom to residual lens epithelial cells within the lens capsule in order to destroy them. The method includes the steps of inserting a probe constructed in accordance with the apparatus of present invention into the eye such that a distal end portion of the probe is disposed either within the lens capsule or between the iris and the lens capsule, delivering energy to the probe such that residual lens epithelial cells within the lens capsule are destroyed, ceasing the delivery of energy to the probe, and removing the probe from the eye.   <IMAGE>   <IMAGE>
Patent DE-69434312-D1 (DE)
Inventor: LANGE THEODOR
IPC: C12N15/53
Filed: 1994-05-24
Granted: 2005-04-28
Abstract: The invention relates to the molecular cloning and expression of a gibberellin (GA) 20-oxidase gene and its use, for example in transgenic plants. Aspects of the invention include recombinant DNA which encodes a polypeptide exhibiting GA 20-oxidase activity, a recombinant polypeptide exhibiting GA 20-oxidase activity, and transgenic plants which express a GA 20-oxidase gene or reverse GA 20-oxidase sequences.
Patent DE-69434807-D1 (DE)
Inventor: KONTINEN VESA
IPC: G01N33/566
Filed: 1994-02-25
Granted: 2006-09-14
Abstract: PCT No. PCT/FI94/00072 Sec. 371 Date Jul. 8, 1996 Sec. 102(e) Date Jul. 8, 1996 PCT Filed Feb. 25, 1994 PCT Pub. No. WO94/19471 PCT Pub. Date Sep. 1, 1994The invention provides a method and expression system for enhancing secretion of hyperproduced homologous and heterologous exoproteins in gram-positive bacteria such as Bacillus sp. The method and system comprise overproduction of PrsA protein in gram-positive bacterial host capable of also overproducing at least one exoprotein of interest. Use of the method and system of the invention results in greatly enhanced secretion of the synthesized exoproteins into the growth medium. Once in the growth medium these secreted exoproteins can be recovered and purified in a straightforward manner.
Patent DE-69435137-D1 (DE)
Inventor: GRAINGER DAVID J
IPC: A61P9/00
Filed: 1994-05-12
Granted: 2008-10-16
Abstract: TGF-beta activators and TGF-beta production stimulators are employed to maintain or increase vessel lumen diameter in a diseased or injured vessel of a mammal. Conditions such as restenosis following angioplasty, vascular bypass grafts, transplanted organs, atherosclerosis or hypertension are characterized by a reduced vessel lumen diameter. In a preferred embodiment of the invention, TGF-beta activators and production stimulators inhibit abnormal proliferation of smooth muscle cells. TGF-beta activators or production stimulators that are not characterized by an undesirable systemic toxicity profile at a prophylactic dose are also amenable to chronic use for prophylactic purposes with respect to disease states involving proliferation and/or migration of vascular smooth muscle cells over time. Further provided is a method for determining TGF-beta in vitro, thereby identifying a patient at risk for atherosclerosis and monitoring a recipient that has received one or more administrations of a TGF-beta activator or production stimulator.
Patent DE-69502705-D1 (DE)
Inventor: MELHUUS TORGRIM
IPC: G09F15/00
Filed: 1995-02-14
Granted: 1998-07-02
Abstract: A large poster mounting frame is provided for displaying a poster along the wall of a building structure. The poster mounting frame comprises a pair of vertical side guide rails and a support rail extending between and connecting the two side guide rails. The frame can be mounted directly on the side of the building structure. The rails have a U-shaped cross-section with the open portion facing inwardly to form a continuous channel. A pair of grooved wheels are rotatably mounted on the support rail and hoist lines are directed over the grooved wheels and are connected to an upper poster carrying rail attached to the upper edge of a large poster. The lower edge of the poster includes a lower carrying rail. The hoist lines are used to raise the poster along with the upper and lower carrying rail into sliding contact with the side guide rails of the frame until the poster is securely mounted and displayed within the frame. Outwardly beveled ends and notches are provided in the bottom ends of the side guide rails to guide the carrying rails into the frame. A reversable motorized shaft can be used along with one or more support tapes for raising and lowering the large poster. A retaining device, such as a cord or net, may be provided across the front face of the side guide rails to further retain the poster within the mounting frame.
Patent DE-69505634-D1 (DE)
Inventor: NOVATI DANIELE
IPC: H02J3/14
Filed: 1995-12-07
Granted: 1998-12-03
Abstract: In the electrical system described, a central control unit (13) sends signals on a data-transmission line (16) to a plurality of peripheral control units (14a, 14b, ... 14n) associated with the electrical sockets (11a, 11b, ... 11n) of the system. The peripheral units in turn receive and send signals on the same line (16). The signals contain address data for the peripheral units and commands for activating and de-activating the sockets. The sockets are activated and de-activated by means of switches (12a, 12b, ... 12n) controlled automatically by the peripheral units according to priority levels which are assigned to them and can be selected on the associated peripheral units, and on the basis of the criterion that, at any moment, the system must be supplied with the maximum power demanded as far as the maximum power available (Pmax) allows. <IMAGE>
Patent DE-69524102-D1 (DE)
Inventor: ELLIOTT G
IPC: A61K39/00
Filed: 1995-07-26
Granted: 2002-01-03
Abstract: Antibodies and fragments thereof which activate an erythropoietin receptor and stimulate erythropiesis are described. Also described are hybridoma cell lines which produce the antibodies and methods and compositions for the treatment of anemia. <IMAGE>
Patent DE-69524246-D1 (DE)
Inventor: SHISHIKURA JUN-ICHI
IPC: A61K31/498
Filed: 1995-09-25
Granted: 2002-01-10
Abstract: A 1,2,3,4-tetrahydroquinoxalinedione derivative represented by the following formula (I) or salt thereof, an NMDA-glycine receptor and/or AMPA receptor antagonist or kainic acid neurotoxicity inhibitor containing the derivative or salt. In addition, a pharmaceutical composition comprising said compound and a pharmaceutically acceptable carrier. <CHEM> wherein symbols in the above formula represent the following meanings, respectively:     X: N, CH,   R: an imidazolyl group or a di-lower alkylamino group,   R<1>:   (1) a halogen atom, a nitro group, a cyano group, a carboxyl group, an amino group, a mono- or di-lower alkylamino group, a lower alkanoyl group, a lower alkylthio group, a lower alkylsulfinyl group, a lower alkylsulfonyl group or a carbamoyl group, (2) a lower alkyl group or lower alkoxyl group which may be substituted by a halogen atom, a carboxyl group or an aryl group, (3) a phenyloxy group which may be substituted by a lower alkoxycarbonyl group or a carboxyl group,   R<2>: a hydroxyl group, a lower alkoxyl group, an amino group or a mono- or di-lower alkylamino group, A: a lower alkylene group which may be substituted or a group represented by the formula -O-B-, and   B: a lower alkylene group, with the proviso that the case wherein R represents an imidazolyl group, R<1> represents a cyano group, A represents an ethylene group and R<2> represents a hydroxyl group is excluded.
Patent DE-69526246-D1 (DE)
Inventor: VAN GEMERT BARRY
IPC: C07D311/94
Filed: 1995-11-03
Granted: 2002-05-08
Abstract: Described are novel photochromic indeno-fused naphthopyran compounds, examples of which are naphthopyran compounds having a substituted or unsubstituted indeno group, the 2,1 positions of which are fused to the f side of the naphtho portion of the naphthopyran, and certain substituents at the 3-position of the pyran ring. Certain substituents may also be present at the number 5, 6, 7, 8, 9, 10, 11, 12, or 13 carbon atoms of the compounds. These compounds may be represented by graphic formula (I). Also described are polymeric organic host materials that contain or that are coated with such compounds. Optically clear articles such as ophthalmic lenses or other plastic transparencies that incorporate the novel naphthopyran compounds or combinations thereof with complementary photochromic compounds, e.g., certain other naphthopyrans, benzopyrans, and spiro(indoline)type compounds, are also described.